Home › Cancro alla prostata › Washington › Spokane Valley
Studi clinici su Cancro alla prostata a Spokane Valley, WA
9 studi su Cancro alla prostata cercano partecipanti presso sedi a Spokane Valley e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
In reclutamentoFase 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · a 14 mi di distanza
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · a 21 mi di distanza
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
In reclutamentoFase 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · a 14 mi di distanza
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · a 21 mi di distanza
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · a 14 mi di distanza
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · a 21 mi di distanza
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
In reclutamentoFase 2
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · a 14 mi di distanza
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · a 21 mi di distanza
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
In reclutamentoFase 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · a 14 mi di distanza
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · a 21 mi di distanza
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
In reclutamentoFase 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · a 14 mi di distanza
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · a 21 mi di distanza
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
In reclutamentoFase 2
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · a 14 mi di distanza
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · a 21 mi di distanza
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
In reclutamentoFase 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · a 14 mi di distanza
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · a 21 mi di distanza
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
In reclutamentoFase 3
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · a 14 mi di distanza
Studi su Cancro alla prostata in altre città
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN42 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Altri studi a Spokane Valley
- Cancro del polmone non a piccole cellule14 studi
- Cancro ai polmoni8 studi
- Cancro al seno8 studi
- Leucemia mieloide acuta7 studi
- Melanoma6 studi
- Carcinoma a cellule squamose della testa e del collo4 studi
- Cancro metastatico4 studi
- Cancro colorettale4 studi
- Cancro del colon4 studi
- Cancro (tutti i tipi)4 studi
- Cancro della vescica4 studi
- Cancro dell'endometrio3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.